COMMUNIQUÉS West-GlobeNewswire

European Medicines Agency Validates Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Review
02/10/2026
LOR is now under regulatory review in both the United Kingdom and the European Union SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a late-stage biopharmaceutical company [...]
The Ensign Group Announces Expansion Into Florida
02/10/2026
SAN JUAN CAPISTRANO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Adds Operations in Washington
02/10/2026
SAN JUAN CAPISTRANO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Adds New Operations in Colorado
02/10/2026
SAN JUAN CAPISTRANO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Digbi Health Unifies Metabolic, Inflammatory and Hormonal Care on One Precision Biology Telehealth Platform
02/10/2026
Employers can now deliver GLP-1 and hormone replacement therapy through a unified care team, without layering on another standalone point solution MOUNTAIN VIEW, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Digbi Health [...]
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
02/10/2026
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS or the “Company”), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that it [...]
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/10/2026
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
02/10/2026
FREDERICK, Md., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced [...]
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
02/10/2026
Late-breaking poster presentation to showcase initial activity of WAL0921 in proteinuric kidney disease Additional poster demonstrates WAL0921 is safe, well tolerated, and reduces circulating suPAR levels in healthy [...]
Published Human Research Gives Family Caregivers a Way to Evaluate Joint Supplements
02/10/2026
Three published human studies of the complete Cartigenix HP formulation offer the kind of named, verifiable evidence a caregiver can bring to a family member's clinician Scottsdale, AZ, Oct. 02, 2026 (GLOBE NEWSWIRE [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2026
CLEVELAND, Ohio, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2026
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that on October 1 [...]
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
02/10/2026
Jena, Germany, Oct. 02, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company [...]
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
02/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four upcoming presentations, including two Late Breaking Clinical Research presentations and two [...]
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2026
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it [...]
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
02/10/2026
First patient expected to be dosed in the DUET study in the fourth quarter of 2026 Milestone triggers second closing of March 2025 private placement expected to provide approximately $95.1M in gross proceeds SOUTH SAN [...]
Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
02/10/2026
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of a proposed $600 million seven-year [...]
Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics
02/10/2026
90% of U.S. infants lack key beneficial microbes necessary for optimal development Deficient microbiomes associated with non-vaginal births, formula feeding and chronic antibiotic use have been linked to asthma, eczema [...]
Celcuity Appoints David Gryska To Its Board Of Directors
02/10/2026
Mr. Gryska brings decades of strategic and financial leadership experience to Celcuity’s Board MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing [...]

Pages